Skip Navigation

December 12, 2022

Press Release | Red Nucleus Expands Medical Communications Business Unit, Acquires AlphaGroup Medical Communications, LLC

Red Nucleus HQ

AlphaGroup logo and Red Nucleus Logo on a textured white and grey background. AlphaGroup logo and Red Nucleus Logo on a textured white and grey background.

Red Nucleus significantly expands its offerings with scientific publication planning and medical affairs acquisition of AlphaGroup.

Yardley, PA – December 12, 2022 – RN, a premier provider of strategic learning and development, scientific services and advisory, medical communications solutions, and market access and commercialization services exclusively for the life sciences industry, announced that it has acquired AlphaGroup, renowned for delivering leading scientific, medical affairs, and outcomes communication services for the pharmaceutical, biotech, and medical device/diagnostic industries. The Company’s services are high science, with over half its employees possessing advanced scientific degrees. AlphaGroup has expansive therapeutic expertise in oncology, virology, transplantation, immunology, rare diseases, gene therapy, and cardiology.

AlphaGroup, founded in 2005 by Stephen Douthwaite, provides a focused set of scientific and medical communications solutions centered on key medical activities throughout a product’s life cycle, beginning in pre-clinical development and spanning through FDA approval, product launch, and continued marketing efforts. The Company brings expertise in the areas of scientific medical communications (including manuscript, abstract, and poster development and strategic publication planning), medical affairs communications (including MSL tools, interactive educational and training tools, slide decks, publications, and KOL engagement), and health economics and outcomes research (HEOR), real world evidence (RWE), and payer communications. AlphaGroup brings new clients and extended services to the combined business.

Mike Smith, AlphaGroup Group Managing Director, said “Our commitment to delivering the highest quality communication services in the industry remains our top priority and was at the forefront of our decision to join Red Nucleus. Their industry reputation, global scale, and infrastructure to support our ongoing rapid growth made this a natural fit for our team and for our clients.”

"We are excited to be joining an organization that shares our core values of precision, integrity, and passion, and we look forward to collaborating closely with the rest of the medical communications business unit within RN to bring extended capabilities to our clients,” AlphaGroup Chief Strategy Officer Ed Shifflett adds.

“As internal and external collaboration grows across the pharmaceutical industry, winning agency partners will demonstrate true integration and a world class customer experience. AlphaGroup extends our Medical Communications capabilities across publications and medical affairs and brings exciting new services within the HEOR and RWE space,” adds Philip McCrea, Global President, Medical Communications at Red Nucleus.

“We are elated AlphaGroup has joined the Red Nucleus family as we continue our relentless drive to bring differentiated value to our clients across the product life cycle as we execute on our strategy of providing capability coverage from molecule to market,” said Red Nucleus CEO Ian Kelly.

The transaction closed in December 2022.
For more information, please contact
Media Contact: Kelly Curtin
(917) 880-3449

About Red Nucleus
We are a global strategic partner with decades of experience across the entire life sciences product life cycle. We excel in providing our clients unique insights and efficiencies to support their journey to improve health outcomes and ultimately the quality of people’s lives. Our “red thread” weaves together a full suite of products and services from advisory, scientific, market access, medical communications, and learning and development that leads our life sciences clients to accelerated transformational success.